1. Aso Y, Boccon-Gibob L, Brendler CB, et al. (1993) Clinical research criteria. In: Cockett AT, Aso Y, Chatelain C, Denis L, Griffith K, Murphy G (eds) Proceedings of the Second International Consultation on Benign Prostatic Hyperplasia (BPH). Paris, SCI: 345–355.
2. Bach D (2000) Placebokontrollierte Langzeittherapiestudie mit Kürbissamenextrakt bei BPHbedingten Miktionsbeschwerden. Urologe 40: 437–43.
3. Bach D, Ebeling L (1996) Long-term drug treatment of benign prostatic hyperplasia–results of a prospective 3-year multicenter study using Sabal extract IDS 89. Phytomedicine 3: 105–1111.
4. Bach D, Schmitt M, Ebeling L (1996) Phytopharmaceutical and synthetic agents in the treatment of benign prostatic hyperplasia ( BPH ). Phytomedicine 3: 309–313.
5. Barry MJ, Fowler FJ Jr, O’Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett ATK (1992) Measurement Committee of the American Urological Association: The American Urological Association symptom index for benign prostatic hyperplasia. J Urol 148: 1549–1557.